ReviewTherapeutic advances in gastroenterology2026
Subcutaneous infliximab in the treatment of patients with perianal fistulizing Crohn's disease: current evidence and emerging roles.
Axel Dignass et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.